GENB

Generate Biomedicines

17.41

+0.91+5.52%

After Hours: 17.73 +0.32 +1.84%19:16 07/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.52/16.50

TODAY RANGE16.48-17.60

VOL833.49K

MARKET CAP2.23B

52 WEEK RANGE11.00-18.18

AVG VOL (3M)735.91K

% TURNOVER0.65%

TURNOVER--

P/E (TTM)-16.3214

% RANGE6.79%

EPS(TTM)-1.0667

P/E(FORWARD)-7.5043

P/B4.335

BVPS4.016

DIVIDEND--

P/S69.58

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.73B

SHARES OUTSTANDING128.19M

NEXT EARNINGS--

FREE FLOAT99.36M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·4d ago
Generate Biomedicines releases corporate presentation on programmable biology platform and clinical-stage pipeline
Seeking Alpha·4d ago
Cathie Wood's weekly recap: boosts AI, crypto bets; cuts Roku, China exposure
TipRanks·06/25 11:50
Analysts Offer Insights on NA Companies: Yesway Inc Class A (YSWY), Generate Biomedicines, Inc. (GENB) and SK hynix Inc. Sponsored GDR (OtherHXSCL)
PR Newswire·06/22 12:00
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts
Seeking Alpha·06/22 11:00
Cathie Wood's Ark Invest weekly recap: Block and Snowflake bought, Roku and Strata liquidated
TipRanks·06/18 10:43
LLY, COIN, HOOD, and ROKU Stocks in Focus: Cathie Wood Sells Winners and Buys New Catalysts — 6/18/26
TipRanks·06/15 11:08
Guggenheim Reaffirms Their Buy Rating on Generate Biomedicines, Inc. (GENB)
PR Newswire·05/28 20:20
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
PUBT·05/28 20:14
Generate Biomedicines to present at Goldman Sachs Global Healthcare Conference
PUBT·05/26 19:24
Generate Biomedicines publishes corporate presentation on programmable biology drug design platform
Dow Jones·05/14 17:25
Generate Biomedicines Price Target Raised to $22.00/Share From $20.00 by Morgan Stanley
Dow Jones·05/14 17:25
Generate Biomedicines Is Maintained at Overweight by Morgan Stanley
TipRanks·05/14 16:37
Generate Biomedicines price target raised to $22 from $20 at Morgan Stanley
TipRanks·05/14 15:16
Generate Biomedicines, Inc. (GENB) Receives a Buy from Morgan Stanley
TipRanks·05/08 12:59
Piper Sandler Sticks to Their Buy Rating for Generate Biomedicines, Inc. (GENB)

Same Industry

Name/Symbol

Change%

Price

Thermo Fishr Sci

TMO

+1.44%

513.03

Waters

WAT

+1.76%

375.36

Danaher Corporation

DHR

+1.77%

197.15

Fulgent Genetics

FLGT

+2.67%

19.96

Resmed

RMD

+4.24%

209.63

Check Point Software Tech Ltd

CHKP

+1.06%

130.11

Agilent Technologies Inc

-2.02%

130.69

ABMD

Ge Healthcare Technologies Inc

GEHC

+0.62%

65.26

Intuitive Surgical Inc

ISRG

+4.90%

422.10

VEEV

Revvity Inc

RVTY

-0.57%

112.38

Edwards Lifesciences Corp

+1.18%

90.78

Inmode Ltd.

INMD

+1.06%

14.84

ATHN

Bruker Corp

BRKR

+1.94%

61.82

VARIAN MEDICAL

VAR

0.00%

0.0000

ITGR

HOLX

Quidel

QDEL

-0.03%

18.18

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.